SUN-739 Next Generation AR Antagonists Increase Systemic Active Glucocorticoid Exposure by Altering Glucocorticoid Metabolism

Enzalutamide and apalutamide are potent next-generation androgen receptor (AR) antagonists used in metastatic and non-metastatic prostate cancer. Despite the increased survival benefits of these agents, resistance normally occurs and the disease transitions to its lethal form. We hypothesized that e...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyamani, Mohammad, Sharifi, Nima, Li, Jianbo, Patel, Mona, Berk, Michael, Taylor, Susan, Przybycin, Christopher, Posadas, Edwin M, Madan, Ravi, Gulley, James L, Rini, Brian I, Garcia, Jorgi A, Klein, Eric A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208944/
http://dx.doi.org/10.1210/jendso/bvaa046.1762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208944/
http://dx.doi.org/10.1210/jendso/bvaa046.1762

Ejemplares similares